Snowden Capital Advisors’s Chemours CC Stock Holding History

Snowden Capital Advisors’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-266	Closed	-$8K	–	1202
2021 Q4	$8K	Buy	+266	New	+$8.29K	﹤0.01%	1571

Other funds holding CC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Snowden Capital Advisors's CC Position: Q1 2022 in Review

Snowden Capital Advisors sold out of Chemours (CC) in Q1 2022, closing a stake of 266 shares — an estimated $8K sold.

Snowden Capital Advisors first reported a position in CC in Q4 2021 and held it in 1 quarter. The position peaked at $8K in Q4 2021. 481 funds tracked by Wall St. Rank hold CC as of Q1 2022.

Snowden Capital Advisors reported no remaining Chemours position as of Q1 2022 after selling out during the quarter.
Snowden Capital Advisors sold 266 Chemours shares in Q1 2022, an estimated $8K.
Snowden Capital Advisors first reported a position in Chemours in Q4 2021 and held it in 1 quarter.
Snowden Capital Advisors's Chemours position peaked at $8K in Q4 2021.
481 funds tracked by Wall St. Rank held Chemours as of Q1 2022.

Based on Snowden Capital Advisors's 13F filing for Q1 2022, filed 16 May 2022.